| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,301 | 1,168 | 326 | 483 | | Cost of Revenue | 1,737 | 2,206 | 905 | 2,916 | | | Gross Profit | 564 | (1,038) | (579) | (2,433) | | | Operating Expenses | | Research Development | 1,020 | 1,353 | 252 | 1,371 | | Selling General and Administrative | 3,679 | 3,537 | 2,043 | 5,993 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 722 | 718 | 685 | 723 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,857) | (6,646) | (3,559) | (10,520) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 38 | 84 | 195 | 687 | | Earnings Before Interest And Taxes | (4,819) | (6,513) | (3,372) | (9,494) | | Interest Expense | 180 | 180 | 243 | 258 | | Income Before Tax | (4,999) | (6,693) | (3,615) | (9,752) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 422 | 49 | (8) | 339 | | | | Net Income From Continuing Ops | (4,577) | (6,693) | (3,615) | (9,752) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,577) | (6,693) | (3,615) | (9,752) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,577) | ($6,693) | ($3,615) | ($9,752) |
|
0.51% Nasdaq 
Income Statement
